Thu, May 1, 2025
Wed, April 30, 2025
Tue, April 29, 2025
Mon, April 28, 2025
Sun, April 27, 2025
Sat, April 26, 2025
Fri, April 25, 2025

Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion

Bengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US based commercial-stage biopharmaceutical company for approximately $3.5...
Merck KGaA, a German science and technology company, is reportedly in advanced discussions to acquire SpringWorks Therapeutics, a U.S.-based biopharmaceutical company, for approximately $3.5 billion. The potential acquisition aims to bolster Merck's oncology portfolio, as SpringWorks focuses on developing treatments for severe rare diseases and cancer. The deal, if finalized, would represent a significant expansion of Merck's capabilities in the biopharmaceutical sector, particularly in the area of targeted cancer therapies.

Read the Full Daily Article at:
[ https://medicaldialogues.in/news/industry/pharma/merck-kgaa-in-late-stage-talks-to-acquire-springworks-for-usd-35-billion-147337 ]